Epigenome Editing: State of the Art, Concepts, and Perspectives.

[1]  Correction of aberrant imprinting by allele‐specific epigenome editing , 2016, Clinical pharmacology and therapeutics.

[2]  D. Segal,et al.  How specific is CRISPR / Cas 9 really ? , 2016 .

[3]  D. Segal,et al.  How specific is CRISPR/Cas9 really? , 2015, Current opinion in chemical biology.

[4]  J. Kelly,et al.  Targeting protein aggregation for the treatment of degenerative diseases , 2015, Nature Reviews Drug Discovery.

[5]  T. Cathomen,et al.  Proven and novel strategies for efficient editing of the human genome. , 2015, Current opinion in pharmacology.

[6]  Christopher M. Vockley,et al.  Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators , 2015, Genome research.

[7]  G. Melino,et al.  Genome-editing tools for stem cell biology , 2015, Cell Death and Disease.

[8]  Hyun-soo Cho,et al.  Direct regulation of E-cadherin by targeted histone methylation of TALE-SET fusion protein in cancer cells , 2015, Oncotarget.

[9]  M. Hottiger.  Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics. , 2015, Annual review of biochemistry.

[10]  Paul R. Thompson,et al.  Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation , 2015, Chemical reviews.

[11]  K. Kaestner,et al.  TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. , 2015, The Journal of clinical investigation.

[12]  Christopher M. Vockley,et al.  Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.

[13]  D. Moazed,et al.  Epigenetic inheritance uncoupled from sequence-specific recruitment , 2015, Science.

[14]  Pin Tong,et al.  Restricted epigenetic inheritance of H3K9 methylation , 2015, Science.

[15]  S. Devine,et al.  Brain feminization requires active repression of masculinization via DNA methylation , 2015, Nature Neuroscience.

[16]  R. Reinhardt,et al.  Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained , 2015, Epigenetics & Chromatin.

[17]  M. Ravichandran,et al.  Synthetic epigenetics—towards intelligent control of epigenetic states and cell identity , 2015, Clinical Epigenetics.

[18]  R. Maehr,et al.  Functional annotation of native enhancers with a Cas9 -histone demethylase fusion , 2015, Nature Methods.

[19]  P. Blancafort,et al.  Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer , 2015, Oncogene.

[20]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[21]  James J. Collins,et al.  Chromatin regulation at the frontier of synthetic biology , 2015, Nature Reviews Genetics.

[22]  J. Li,et al.  Structural insight into autoinhibition and histone H3-induced activation of DNMT3A , 2014, Nature.

[23]  A. Jeltsch,et al.  DNMT1-associated DNA methylation changes in cancer , 2015, Cell cycle.

[24]  Martin J. Aryee,et al.  GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.

[25]  Feng Zhang,et al.  In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 , 2014, Nature Biotechnology.

[26]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[27]  A. Csoka,et al.  Cellular reprogramming for understanding and treating human disease , 2014, Front. Cell Dev. Biol..

[28]  E. Nestler,et al.  Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors , 2014, Nature Neuroscience.

[29]  B. Chithrani,et al.  Applications of nanoparticles in nanomedicine. , 2014, Journal of biomedical nanotechnology.

[30]  A. Ferguson-Smith,et al.  Epigenetic Control of the Genome—Lessons from Genomic Imprinting , 2014, Genes.

[31]  Peggy J. Farnham,et al.  Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation , 2014, Nucleic acids research.

[32]  James J. Collins,et al.  Using Targeted Chromatin Regulators to Engineer Combinatorial and Spatial Transcriptional Regulation , 2014, Cell.

[33]  A. Jeltsch,et al.  New concepts in DNA methylation. , 2014, Trends in biochemical sciences.

[34]  T. Mashimo,et al.  Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR–Cas platform , 2014, Nature Communications.

[35]  N. Brockdorff,et al.  Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation , 2014, Cell.

[36]  Claudio Mussolino,et al.  TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity , 2014, Nucleic acids research.

[37]  X. Wang,et al.  Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5′-LTR promoter , 2014, Gene Therapy.

[38]  D. Margolis,et al.  Emerging strategies to deplete the HIV reservoir , 2014, Current opinion in infectious diseases.

[39]  Albert Jeltsch,et al.  Targeted Methylation of the Epithelial Cell Adhesion Molecule (EpCAM) Promoter to Silence Its Expression in Ovarian Cancer Cells , 2014, PloS one.

[40]  Guo-Liang Xu,et al.  Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter , 2013, Nucleic acids research.

[41]  Jeffry D Sander,et al.  Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins , 2013, Nature Biotechnology.

[42]  Yi Zhang,et al.  TET enzymes, TDG and the dynamics of DNA demethylation , 2013, Nature.

[43]  Yanming Wang,et al.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. , 2013, Biochimica et biophysica acta.

[44]  B. Ren,et al.  Mapping Human Epigenomes , 2013, Cell.

[45]  J. Joung,et al.  Locus-specific editing of histone modifications at endogenous enhancers using programmable TALE-LSD1 fusions , 2013, Nature Biotechnology.

[46]  L. Kobzik,et al.  Specific transcriptional enhancement of inducible nitric oxide synthase by targeted promoter demethylation , 2013, Epigenetics.

[47]  H. Madhani,et al.  Division of labor between the chromodomains of HP1 and Suv39 methylase enables coordination of heterochromatin spread. , 2013, Molecular cell.

[48]  C. Barbas,et al.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.

[49]  Randall J. Platt,et al.  Optical Control of Mammalian Endogenous Transcription and Epigenetic States , 2013, Nature.

[50]  M. Rots,et al.  Towards Sustained Silencing of HER2/neu in Cancer By Epigenetic Editing , 2013, Molecular Cancer Research.

[51]  E. Binder,et al.  Allele-specific epigenetic modification: a molecular mechanism for gene-environment interactions in stress-related psychiatric disorders? , 2013, Epigenomics.

[52]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[53]  Albert Jeltsch,et al.  Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. , 2013, Journal of molecular biology.

[54]  J. Sweatt,et al.  Epigenetic regulation of memory formation and maintenance. , 2013, Learning & memory.

[55]  Jacques Côté,et al.  Histone phosphorylation , 2012, Epigenetics.

[56]  Pernette J. Verschure,et al.  Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes , 2012, Nucleic acids research.

[57]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[58]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[59]  S. Akbarian,et al.  Epigenetic mechanisms in neurological disease , 2012, Nature Medicine.

[60]  Nouri Nayerossadat,et al.  Viral and nonviral delivery systems for gene delivery , 2012, Advanced biomedical research.

[61]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[62]  S. Yamanaka.  Induced pluripotent stem cells: past, present, and future. , 2012, Cell stem cell.

[63]  E. Greer,et al.  Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.

[64]  Pilar Blancafort,et al.  Epigenetic reprogramming of cancer cells via targeted DNA methylation , 2012, Epigenetics.

[65]  Jian Cao,et al.  Histone Ubiquitination and Deubiquitination in Transcription, DNA Damage Response, and Cancer , 2012, Front. Oncol..

[66]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[67]  D. Christianson,et al.  Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. , 2011, Current opinion in structural biology.

[68]  A. Bogdanove,et al.  TAL Effectors: Customizable Proteins for DNA Targeting , 2011, Science.

[69]  T. Cathomen,et al.  On target? Tracing zinc-finger-nuclease specificity , 2011, Nature Methods.

[70]  S. Dent,et al.  The role of deubiquitinating enzymes in chromatin regulation , 2011, FEBS letters.

[71]  A. Jeltsch,et al.  Structure and Function of Mammalian DNA Methyltransferases , 2011, Chembiochem : a European journal of chemical biology.

[72]  D. Reinberg,et al.  The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation* , 2010, The Journal of Biological Chemistry.

[73]  Yi Zhang,et al.  Active DNA demethylation: many roads lead to Rome , 2010, Nature Reviews Molecular Cell Biology.

[74]  Yang Shi,et al.  Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. , 2010, Annual review of biochemistry.

[75]  Tracy O'Connor,et al.  Protein aggregation diseases: pathogenicity and therapeutic perspectives , 2010, Nature Reviews Drug Discovery.

[76]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[77]  M. Szyf.  Epigenetics, DNA methylation, and chromatin modifying drugs. , 2009, Annual review of pharmacology and toxicology.

[78]  Jon R. Wilson,et al.  Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks. , 2009, Molecular cell.

[79]  Christopher E. Berndsen,et al.  Catalysis and substrate selection by histone/protein lysine acetyltransferases. , 2008, Current opinion in structural biology.

[80]  M. Szyf,et al.  Epigenetic Programming of Phenotypic Variations in Reproductive Strategies in the Rat Through Maternal Care , 2008, Journal of neuroendocrinology.

[81]  T. Abel,et al.  Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. , 2008, Current opinion in pharmacology.

[82]  B. Horsthemke,et al.  Genomic imprinting and imprinting defects in humans. , 2008, Advances in genetics.

[83]  A. Jeltsch,et al.  Application of DNA methyltransferases in targeted DNA methylation , 2007, Applied Microbiology and Biotechnology.

[84]  Albert Jeltsch,et al.  Chimeric DNA methyltransferases target DNA methylation to specific DNA sequences and repress expression of target genes , 2006, Nucleic acids research.

[85]  Peter A. Jones,et al.  Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.

[86]  Robert E Collins,et al.  Structural and sequence motifs of protein (histone) methylation enzymes. , 2005, Annual review of biophysics and biomolecular structure.

[87]  L. Guarente,et al.  The Sir2 family of protein deacetylases. , 2004, Annual review of biochemistry.

[88]  Carl O. Pabo,et al.  Drug discovery with engineered zinc-finger proteins , 2003, Nature Reviews Drug Discovery.

[89]  C. Pabo,et al.  Gene-Specific Targeting of H3K9 Methylation Is Sufficient for Initiating Repression In Vivo , 2002, Current Biology.

[90]  C. Pabo,et al.  Design and selection of novel Cys2His2 zinc finger proteins. , 2001, Annual review of biochemistry.

[91]  C. Pabo,et al.  DNA recognition by Cys2His2 zinc finger proteins. , 2000, Annual review of biophysics and biomolecular structure.

[92]  T. Bestor,et al.  Cytosine methylation targetted to pre-determined sequences , 1997, Nature Genetics.

[93]  W Wende,et al.  Engineering novel restriction endonucleases: principles and applications. , 1996, Trends in biotechnology.

[94]  N. Seeman,et al.  Sequence-specific Recognition of Double Helical Nucleic Acids by Proteins (base Pairs/hydrogen Bonding/recognition Fidelity/ion Binding) , 2022 .